US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.
On Tuesday, Halliburton (HAL.US) rose over 9% to $24.73.
On Tuesday, Halliburton (HAL.US) rose more than 9%, reaching $24.73. In terms of news, Halliburton reported its third quarter results: non-GAAP earnings per share were $0.58, exceeding expectations by $0.08. Revenue reached $5.6 billion, higher than the IBES estimate of $53.9 billion.
Related Articles
EVEREST MED (01952) holds a corporate development strategy exchange meeting to strengthen global layout and achieve leapfrog development strategy.
Revenue increased by 15% and profits surged by 27%, Western Alliance (WAL.US) Q3 financial report exceeded expectations and dispelled regional bank fears.
INNOVENT BIO (01801) and Takeda Pharmaceutical reached a global strategic cooperation agreement and issued shares under general authorization.
EVEREST MED (01952) holds a corporate development strategy exchange meeting to strengthen global layout and achieve leapfrog development strategy.
Revenue increased by 15% and profits surged by 27%, Western Alliance (WAL.US) Q3 financial report exceeded expectations and dispelled regional bank fears.
INNOVENT BIO (01801) and Takeda Pharmaceutical reached a global strategic cooperation agreement and issued shares under general authorization.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
